Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells (Q33637970)

28 July 2017

1 reference

title

Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells (English)

1 reference

28 July 2017

N Düzgüneş

1

1 reference

28 July 2017

E Pretzer

2

1 reference

28 July 2017

S Simões

3

1 reference

28 July 2017

V Slepushkin

4

1 reference

28 July 2017

K Konopka

5

1 reference

28 July 2017

D Flasher

6

1 reference

28 July 2017

M C de Lima

7

1 reference

28 July 2017

1 January 1999

1 reference

Molecular Membrane Biology

28 July 2017

1 reference

28 July 2017

16

1 reference

28 July 2017

1

1 reference

28 July 2017

111-118

1 reference

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity

28 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Gene therapy and immune restoration for HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Antisense oligonucleotides as antiviral agents: prospects and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

pH-sensitive liposomes: acid-induced liposome fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Intracellular delivery of nucleic acids and transcription factors by cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

H+- and Ca2+-induced fusion and destabilization of liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Improved cationic lipid formulations for in vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

The role of mononuclear phagocytes in HTLV-III/LAV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Activation of a Diphtheria Toxin A Gene by Expression of Human Immunodeficiency Virus-1 Tat and Rev Proteins in Transfected Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Therapy for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

HIV protease: a novel chemotherapeutic target for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Present status and future prospects for HIV therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Viral proteinases: weakness in strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Cationic liposome-mediated expression of HIV-regulated luciferase and diphtheria toxin a genes in HeLa cells infected with or expressing HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Long-term noncytopathic productive infection of the human monocytic leukemia cell line THP-1 by human immunodeficiency virus type 1 (HIV-1IIIB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Characterization of plasma-stabilized liposomes composed of dioleoylphosphatidylethanolamine and oleic acid [published errtum appears in Biochem Biophys Res Commun 1989 Sep 29;163(3):1539].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

New concepts in the immunopathogenesis of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Gene therapy: a bold direction for HIV-1 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Targeting of liposomes to HIV-1-infected cells by peptides derived from the CD4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Antisense technology and prospects for therapy of viral infections and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

In vitro evolution of functional nucleic acids: high-affinity RNA ligands of HIV-1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F096876899294832

21 January 2018

Identifiers

DOI

10.1080/096876899294832

1 reference

28 July 2017

1 reference